ENG/中
老虎证券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Gemphire Therapeutics Inc.
0.3000
0.0000
成交量：
- -
成交额：
- -
市值：
446.17万
市盈率：
-0.31
高：
0.3000
开：
0.3000
低：
0.3000
收：
0.3000
52周最高：
1.49
52周最低：
0.2380
股本：
1,487.24万
流通股本：
1,028.40万
量比：
- -
换手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-0.9678
每股收益(LYR):
-1.7121
净资产收益率：
-280.97%
总资产收益率：
-44.90%
市净率：
2.27
市盈率(LYR):
-0.18
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字：
Gemphire Therapeutics Inc.
交易所：
NASDAQ
成立时间：
- -
员工人数：
- -
公司地址：
- -
官网：
http://www.gemphire.com
邮编：
- -
电话：
- -
传真：
- -
简介：
Gemphire Therapeutics Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。公司是一家临床阶段的生物制药公司，致力于将用于治疗血脂异常，即一种会增加威胁生命的心血管疾病风险的严重的疾病疗法的研究开发和商业化。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/GEMP/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"GEMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GEMP\",,,,,undefined,":{"symbol":"GEMP","market":"US","secType":"STK","nameCN":"Gemphire Therapeutics Inc.","latestPrice":0.3,"timestamp":1577739600000,"preClose":0.3,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":10283980,"shares":14872411,"eps":-0.967778,"marketStatus":"休市中","change":0,"latestTime":"12-30 16:00:00 EST","open":0.3,"high":0.3,"low":0.3,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.967778,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"NRBO","executeDate":"2019-12-31"},"adr":0,"adrRate":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":0.3,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GEMP\",,,,,undefined,":{"symbol":"GEMP","floatShares":10283980,"roa":"-44.90%","roe":"-280.97%","lyrEps":-1.712137,"shares":14872411,"dividePrice":0,"high":0.3,"amplitude":0,"preClose":0.3,"low":0.3,"week52Low":0.238,"pbRate":"2.27","week52High":1.485,"institutionHeld":0,"latestPrice":0.3,"eps":-0.967778,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.967778,"open":0.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GEMP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-12-31","symbol":"GEMP","oldSymbol":"GEMP","newSymbol":"NRBO","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1577768400000},{"market":"US","date":"2019-12-31","symbol":"GEMP","type":"split","dateTimestamp":1577768400000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2019-08-09","symbol":"GEMP","fiscalQuarterEnding":"2019/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1565323200000,"reportTimeType":"","actualEps":-0.2},{"market":"US","date":"2019-05-09","symbol":"GEMP","fiscalQuarterEnding":"2019/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1557374400000,"reportTimeType":"","actualEps":-0.27},{"market":"US","date":"2019-03-15","symbol":"GEMP","fiscalQuarterEnding":"2018/12","expectedEps":-0.39,"name":null,"time":"","type":"earning","dateTimestamp":1552622400000,"reportTimeType":"","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GEMP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GEMP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.gemphire.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gemphire Therapeutics Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。公司是一家临床阶段的生物制药公司，致力于将用于治疗血脂异常，即一种会增加威胁生命的心血管疾病风险的严重的疾病疗法的研究开发和商业化。","exchange":"NASDAQ","name":"Gemphire Therapeutics Inc.","nameEN":"Gemphire Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GEMP\",market:\"US\",,,undefined,":null}}